Exclusive

Publication

Byline

बांका : जनगणना पर्यवेक्षक के बीच किट का वितरण

बांका, मई 12 -- धोरैया (बांका), निज प्रतिनिधि। प्रखंड अंतर्गत जनगणना के सफलता पूर्वक कार्य संपादन हेतु जनगणना पर्यवेक्षक को चार्ज अधिकारी सह बीडीओ अरविंद कुमार द्वारा किट का वितरण किया गया। बीडीओ ने ब... Read More


बांका : फरार अभियुक्त के घर इश्तेहार चस्पा

बांका, मई 12 -- चान्दन (बांका), निज प्रतिनिधि। आनंदपुर थाना कांड संख्या-22/25 के फरार अभियुक्त नीतीश कुमार, पिता सहदेव यादव, ग्राम दिग्गीबारी थाना आनंदपुर जिला बांका के घर पर मंगलवार को पुलिस द्वारा न... Read More


एलआरडीसी ने चैनपुर में विभिन्न सरकारी संस्थानों किया औचक निरीक्षण

गुमला, मई 12 -- चैनपुर प्रतिनिधि। एलआरडीसी कंचन सिंह ने मंगलवार को चैनपुर पंचायत के विभिन्न सरकारी संस्थानों और योजनाओं का औचक निरीक्षण कर स्वास्थ्य,शिक्षा और जन वितरण प्रणाली की जमीनी हकीकत परखी। निर... Read More


गुमला में 15 मई से सजेगा चार दिवसीय भव्य पुस्तक मेला

गुमला, मई 12 -- गुमला प्रतिनिधि। शहर में बड़े स्तर पर चार दिनी भव्य पुस्तक मेले का आयोजन किया जा रहा है। 15 से 18 मई तक टाउन हॉल में आयोजित होने वाला यह मेला विद्यार्थियों, शिक्षकों, प्रतियोगी परीक्षा... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 12 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 12 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, May 12 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the pos... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, May 12 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... Read More